Enzo Clincal Labs Joins Empire BlueCross BlueShield Network

Aug 03, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Health insurer Empire BlueCross BlueShield has included Enzo Clinical Labs in its provider network covering the metropolitan New York City area.

Coverage became effective Aug. 1, Enzo's parent firm, Enzo Biochem, and Empire BCBS jointly said today.

Coverage for Enzo's services is included in Empire PPO Plans, Empire EPO Plans, and Empire Indemnity Plans. The clinical lab, which is a wholly owned subsidiary of Enzo Biochem, provides clinical, cytology, and anatomic pathology services, as well as molecular, genetic, and ancillary testing, and customized test panels and profiles.

Empire BCBS is New York State's largest health insurer.

Filed under

Reimbursement News

Molecular Diagnostics

genetic testing

Enzo

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.